Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa randomized double-blind placebo-controlled dose-finding study of YMP transdermal patch for perioperative sleep disorder
CTR20263494Phase 2Active
- Sponsor
- Beijing Tide Pharmaceutical Co., Ltd.
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexmedetomidine, YMP in sleep disorder, sponsored by Beijing Tide Pharmaceutical Co., Ltd.. Started Sep 2026; status: active.
02
Drugs
dexmedetomidineYMP
03
Conditions
sleep disorder
Beyond the preview
Go deeper on CTR20263494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263494.